OpenVSafe by OpenVAERS
Search V-safe

V7W-22663-59367

3 vaccinations 1 coded response 2 check-ins 1 free-text entry 0 call cases
Sex
Male
Age at first dose
21-25
ZIP prefix
954 / CA
Registered
2022-05-03
Relationship
Child or adolescent in my care
Guardian
73M-12050-44603
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-23
    Dose 1 — Pfizer-BioNTech
  2. 2021-04-13
    Dose 2 — Pfizer-BioNTech
  3. 2022-01-14
    Dose 3 — Moderna
  4. 2022-05-03
    Registered in v-safe
  5. 2022-07-15
    Survey response — 6 months, dose 3, dependent
    MedDRA: Headache, Nasal congestion, Rhinorrhoea, Sinus congestion — Feeling: Fair · Be unable to work or attend school
    Free text: Nasal, sinus congestion, runny nose, headache
    MedDRA releases: 2024-11 · check-in free text available
  6. 2023-01-14

Vaccinations

DoseDateManufacturerCo-administered
12021-03-23Pfizer-BioNTech No
22021-04-13Pfizer-BioNTech No
32022-01-14Moderna No

Free text

Release 12 — 6 months, dose 3, dependent

2022-07-15

Symptoms: Nasal, sinus congestion, runny nose, headache

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDHeadache · · ✓
SDNasal congestion · · ✓
SDRhinorrhoea · · ✓
SDSinus congestion · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release